We have recently made a third-party allotment of shares to several operating companies, including Ryoko Co., Ltd.
We are currently promoting the nationwide expansion of “N-NOSE at home *”, which completes the process of applying for tests, submitting samples, and receiving results while at home. With this capital increase, we will build a stronger testing system and build a stronger testing system. We will strive to improve the value of our services.
We as HIROTSU Bio Science Inc. (Head Office: Chiyoda-ku, Tokyo; Representative: Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”) are pleas . . .
2024.04.01On March 18, 2024, an reveiw articles on cancer screening by a third-party research team (Romania) was published in "Cancers", an oncology journ . . .
2024.03.29HIROTSU Bioscience Inc. (Head Office: Chiyoda-ku, Tokyo, Representative: Takaaki Hirotsu, hereinafter referred to as “HIROTSU) has verified the . . .
2024.02.29